In this segment, Dr. Morrison discusses the clinical evidence supporting subcutaneous immunotherapy and explains the concept ...

LOS ANGELES -- Patients with metastatic melanoma have faced grim prospects: the American cancer society says the five-year survival rate is only 15 percent. That started changing when the FDA approved ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. While it may give billions of people worldwide painful cold sores, a common virus could be harnessed to provide a ...

By Padmanabhan Ananthan and Sruthi Narasimha Chari April 10 (Reuters) - The U.S. Food and Drug Administration on Friday ...

Various agents are being tried in combination with pembrolizumab for the treatment of advanced melanoma in an attempt to improve the response to pembrolizumab. As noted in this previous Reading Room ...

The FDA has approved a groundbreaking therapy for patients with late-stage melanoma. Melanoma is an aggressive skin cancer that's the fifth most deadly. Too much sun is the leading cause of skin ...

Replimune disagrees with the FDA about whether the data set, upon which breakthrough therapy designation was awarded, is sufficient to allow this promising medicine to be made available to advanced ...

The FDA in a complete response letter to Replimune maintained its original objection to the single-arm trial the biotech used ...

Replimune received a second FDA complete response letter for RP1 in advanced melanoma, raising questions about the viability of its oncolytic immunotherapy program. Replimune Group received a complete ...

Treatment with Cylembio plus pembrolizumab was associated with an improvement in PFS compared with pembrolizumab monotherapy; however, the results missed the study’s statistical significance threshold ...

Johnson and Johnson kicked off first-quarter earnings season with a “modest” beat and an ambitious goal; Replimune failed ...

The News On 6 weekend team provides a comprehensive look at updated news events, a detailed and up-to-the-minute weather forecast, and the latest sports highlights. TULSA, Okla. - The FDA has approved ...